← Human Trials & Peer-Reviewed Studies
A high-glycemic index, low-fiber breakfast affects the postprandial plasma glucose, insulin, and ghrelin responses of patients with type 2 diabetes in a randomized clinical trial
Plain-language guide to PMID 25833777 (2015): crossover randomized controlled trial study of Ghrelin in 14 patients.
Key Facts
- PMID
- 25833777
- Journal
- The Journal of nutrition
- Year
- 2015
- Study type
- Randomized Controlled Trial
- Authors
- Silva FM et al. (4 authors)
- DOI
- 10.3945/jn.114.195339
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial paper looks at Ghrelin.
The aim of this study was to investigate the effect of 4 breakfasts with a different GI and amount of fiber on postprandial plasma glucose, insulin, and appetite in patients with type 2 diabetes.
A visual analog scale was used to assess appetite.
Who Took Part
The study group was 14 patients.
PubMed indexes the participants as middle-aged adults and older adults, both men and women.
How the Study Was Run
The design is described as randomized and crossover.
The patients were allocated by chance, so the Ghrelin group and the comparison group should start out alike.
In the crossover set-up each of the patients took both Ghrelin and the comparison in turn, acting as their own control.
Plasma glucose, insulin, and total ghrelin were evaluated postprandially (0-180 min).
Data are reported as means ± SDs.
What Was Measured
Topics PubMed links to this paper include Appetite, Blood Glucose, Breakfast, Diabetes Mellitus, Type 2, Dietary Fiber, Ghrelin and Glycemic Index.
The authors tagged it with the keywords plasma ghrelin and plasma glucose.
What This Means in Plain Language
The paper is a randomized and crossover study of Ghrelin in 14 patients.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The abstract goes on to report its results in about 7 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2015 (The Journal of nutrition), a journal based in United States.
More context: the Ghrelin compound page, all human trials.
Our Notes on the Compound
Ghrelin: A 28-amino-acid stomach hormone that signals hunger and triggers growth hormone release; studied in human trials as an infusion.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.